On Monday 23rd July, Aurelius Investments Limited (“Aurelius”) confirmed that it has completed the acquisition of Transform Medical Group (“Transform”) from Candlewick Asset Management, a joint venture investment company owned by Goldman Sachs and TPG Capital.
Transform is one of the UK’s leading providers of surgical and non-surgical cosmetic procedures, operating through 27 clinics across the UK and two dedicated cosmetic surgery hospitals in Manchester and London. It also has partnerships with third-party hospitals across the UK.
Aurelius is the UK subsidiary of Aurelius AG, the Germany listed pan-European investment group.
Dr. Dirk Markus, Chief Executive of Aurelius Group, commented:
“Transform is a market leader in cosmetic surgery in the UK. Over the past 40 years, following investment into a vertically integrated national network of hospitals and clinics, Transform has developed an enviable reputation for clinical excellence, regulatory compliance and high quality aftercare. We look forward to working with the Company to grow the business in a sector that is currently experiencing attractive demand drivers.”
Smith Square acted as financial adviser to Aurelius.